Lv11
99646 积分 2020-10-16 加入
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
27天前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
27天前
已完结
糖皮质激素对非小细胞肺癌患者接受免疫检查点抑制剂的疗效影响
2个月前
已完结
Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid Tumors
2个月前
已关闭
Anti-drug Antibodies Monitoring in Biologics Use: Clinical Implications
2个月前
已完结
Antidrug Antibodies and Drug Development: Challenges in the Immunotherapy Era
2个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
2个月前
已完结
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
4个月前
已完结
黄葵胶囊治疗慢性肾脏病临床应用专家共识（2025版）
5个月前
已完结
间变性淋巴瘤激酶酪氨酸激酶抑制剂治疗非小细胞肺癌指南（2025版）
6个月前
已关闭
[Effects of COS on promoting the pathological ovarian aging mice ovarian function by regulating immune function]
25天前
已采纳
[Therapeutic effect of infliximab on moderate and severe active rheumatoid arthritis]
25天前
已采纳
[1,2,6-tri-O-galloyl-beta-D-glucopyranose inhibits gp41-mediated HIV envelope fusion with target cell membrane]
25天前
已采纳
[TET2 gene in hematological diseases]
25天前
已采纳
[Expression, identification and bioactivity characterization of an anti-CD3/anti-CD20 bispecific single-chain antibody]
25天前
已采纳
[Prelimary study of TFA in surface water of some cities over China]
25天前
已采纳
[Effects of free fatty acids on nitric oxide synthase activity and mRNA expression in endothelial cell of SD rat aorta]
25天前
已采纳
[Serological and Molecular Biological Analysis of Rare Cases of p-Blood Type]
25天前
已采纳
REE geochemistry of suspended sediments from the rivers around the Yellow Sea and provenance indicators
25天前
已采纳
Preparation and adsorption mechanism of rare earth-doped adsorbent for arsenic(V) removal from groundwater
25天前
已采纳
皖公网安备34019202002308
